Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here Gold, Let someone else do your homework for you so we can assure you the correct answers. We don't want for you to not pay another nice doctor who goes out of his way to provide you a service you requested...even though it is not a very good service to rely upon. Maybe you should ask that guy what he is really looking for next time before you assume the position? Fleas or allergies?
Gold stated,"Why would I want a RECAF or a PSA test when the DRE's continued to show an absolutely normal prostate.
How about these other absolutely normal prostates for discussion? Are they false positives or false negatives? Which answer were you given twice a year? Could you be in the mix of the 274 poor saps as you call them that were missed?
Gold, you stated that you are 64 +/- and also stated you were 90 years +/- depending on where and when you post so we will assume that you are at least over the age of 45.
Using an average primary care group of 100,000 people. If screening with DRE were applied to all men over 45 years (about 17,000 of them), that would mean 359 cancers detected, 274 cancers missed, and 1454 men with positive DRE who would have to be biopsied to exclude them actually having cancer.'
Yes, there are false positives in a DRE. They are benign conditions. Now, if RECAF poses a problem because it does not distinguish the very aggressive cancers from the slow growing cancers, DRE does not distinguish between cancer and benign tumors, which is worse in terms of doing unnecessary biopsies on the latter. Moreover, if 274 cancers were missed and 359 were detected, then the total number of cancers is 274+359=633. Since DRE picked up only 359 of them, the sensitivity is 359/633=57%. A DRE will catch 2-3 false positives for each cancer it finds and will not pick up about 1/2 of the cancers...
Now maybe you can tell the board,"Why you would want a RECAF or a PSA test when the DRE's continued to show an absolutely normal prostate??????
Gosh Gold... After all of those DRE's You didn't know? Maybe you should look up that vet and pay him his $100 dollars...
A digital rectal examination allows a doctor to feel only the back wall of the prostate gland, so any abnormalities located in the middle or front part of the gland cannot be felt.
Now Gold do you understand how you get a false positive DRE?
Gold stated,"The DRE does not have a high false positive rate. The use of the procedure allows a physician to determine if a prostate is normal or abnormal. You apparently are totally confused about a normal or abnormal prostate. A normal prostate is smooth, no lumps or no hardness."
Gold, Do you choose your apples at the store the same way. Just look at the the back wall of them or do you look at the entire apple to see if it has worm holes or bruises or soft spots? You know ...Lumps or Hardness on the entire Apple's surface.
Gold stated, "You see Half, a DRE is highly accurate and considered the "gold standard" to determine if a prostate is normal."
Why then did you recently stop getting your regular two DRE's per year?
Further, The DRE is very prone to false positives. How do you feel about false positives Gold?
Gold, your use of only the DRE highlights your ignorance of medical procedures. You seem to be blindly supporting a DRE while rejecting everything else.
Gold stated,"The DRE is the "gold standard" for detecting abnormalities of the prostate. It is highly accurate."
Gold...You just stated an open ended comment. All tests are highly accurate for detecting abnormalities, but not all are good at detecting cancer. While an enlarged prostate can indicate a tumor, often it signals a common benign prostate condition.
The DRE is not highly accurate for detecting Cancer in the body. Further one could get a DRE on Monday, get an all clear, and then be diagnosed with any number of terminal cancers on Tuesday inclusive of prostate cancer. Great test Gold!
Gold also stated, "if you have been getting a PSA test without the DRE, you are not in compliance with the approved test procedures."
Funny you say this...You are the one who subscribes to the DRE but will not get the PSA test. So you my friend are not in compliance with the approved test procedures.
In effect you have been treating the cat improperly for symptoms of an allergy just like the Vet that you didn't pay as a result of his Dereliction of Duty.
Gold, How do you explain these?
From: http://www.k9cushings.com/forum/showthread.php?t=837
Lori,
Thank you for posting this! It is a huge breakthrough and promises to be one of the most important diagnostic tests in this century. I read your post quickly. Did the information say what kinds of cancers can be identified? I'll go back and click the link.
Candy
From: http://www.mastiffonlinecommunity.net/viewtopic.php?p=270271
- Interesting, I will have to check it out. Thanks for posting this.
- wonderful !
- That sounds like great news. I wonder what the cost will be and how soon it would be available in my area, I know this is something I would include in Maggie's senior bloodwork
Missy
- This could be a great help if it passes all the studies.
- This is great!
From: http://www.epettalk.com/forums/showthread.php?61379-First-blood-test-unveiled-for-cancer-detection-in-dogs
- Wow I hope it really does do what it says.. that could be great to get the good or bad news faster!
- I know! Just think of hoe much faster we could find things and hopefully prevent lots of deaths.
So many holes in this one!
The test does not provide information regarding the type of cancer or at what stage the cancer is at or if it has metastasized (spread).
And what test does, I ask?
What would be the point of running a test? If a dog shows clinical signs of lymphoma, you could pay the $120 for this blood test, or you could simply send in an aspirate of a swollen lymphnode.
Clinical signs of lymphoma can also be signs of any number of non cancerous issues.
Not to mention the fact if a dog is showing clinical signs and you know it's lymphoma
Stop right there! How does one KNOW it is lymphoma?
all this test does is tell you that the dog definitely has some kind of cancer.
Never short change the diagnosis process. Knowing the dog has cancer is critical in how one proceedes with care.
I mean... we've had one bone cancer patient that looked like bone cancer at first, sent the rads in to a specialist the specialist said the dog had osteoporosis,
OOPS. Stop here again. Do you mean that the vet didn't know it was cancer? Would he/she have known with a Recaf test? This comment proves the usefulness of a true cancer test Gold! They are currently guessing as shown above.
Below is evidence that the Vet missed the diagnosis of cancer and treated the dog improperly. Should have used RECAF first.
treated with pain meds, rechecked in 3mos when the dog was getting worse and it was definitely bone cancer.
So why then were they treating the dog for osteoporosis when the dog actually had bone cancer? Again this bodes well for RECAF!
So I'm not really sure how I feel about this because I feel like there's already enough ways to diagnose cancer.
OOPS! With all of the "enough ways to diagnose cancer", They sure screwed that dog and his owner with the osteoporosis diagnosis....What happened to the "enough ways to diagnose cancer" theory?
I guess if your specialist is unsure about a lump or something you could run it,
OOPS....Stop here again. This is reminding me of the Digital Rectal Exam again...How is the doctor supposed to be sure about the lump? Do cancerous lumps have a big "C" for cancer written on them? NO! Doctors can only get an idea of a lumps' diagnosis by biopsy....The author of the post is also assuming a lump has been found...And is assuming that "ALL" lumps have been found on the surface of a creature covered almost entirely by thick fur. Further, how about internal lumps that can not be seen from the surface? i.e the dog seems unhealthy, lets just choose the osteoporosis theory on this one...We already have "enough ways to diagnose cancer" right?
but again it doesn't tell you where the cancer is or what it is so you couldn't necessarily make a diagnoses off of the results because it just tells you the dog has it somewhere in the body.
Great theory! They screwed up the osteoporosis misdiagnosis so lets also mangle up the test that would have led them in the correct direction to begin with.....I must add that NO current diagnostic tests tell you where the cancer is or what it is so you couldn't necessarily make a diagnoses off of any current results from any cancer test because they just tell you the dog has it somewhere in the body.
I hope this is making sense.
No...It makes absolutely NO SENSE. How is the dog with the osteoporosis...I mean the BONE CANCER that was misdiagnosed by current methods?I think these VETS need to push it a little further and quit misdiagnosing our loved ones.
call2arms » October 16th, 2010, 8:11 pm
I agree with you, either lymph node, or tumor aspirate just has to be sent to histopath, and you know exactly (most of the time)
what it is.
OOPS. The disclamers are flying again...."(most of the time)"
More disclaimers to come...
For more internal stuff, usually x-rays or echography will show masses, nodules or change in echogenicity of tissues.
And of these found or not found, which ones are cancerousand which are not? And there's already a test called hypercalcemia of malignancy (Idexx) that can indicate presence of cancer, if calcium is elevated in the routine blood test.
And does the hypercalcemia of malignancy (Idexx) show where all of the cancer is in the body?
Please do pass this on to your friend Gold..
Gold stated"Have you figured out why Moro "relaunched" Dog RECAF?"
Yes I have.... Have You yet?
Gold, It is interesting to watch you guess at events and their predecessor / successor and each relationship between in order to learn what is really going on. I have figured out that you ask a question in such a way that someone in the know corrects you and thereby provides you with information you were seeking.
The truth is that Dr. Moro and team really just play tennis & golf all day long. They tell the shareholders and the "non-shareholders" that they are hard at work.
The Russians & Goshen & Abbott & Alere & VetRed & Quantrx & bankers & analysts and Even the ISOBM group are really talking with a Dr. Moro stand in when they call.
He sounds just like Dr. Moro and has a buzzword sheet with all of the big Bio words on it. Works every time.
Gold, You assume an awful lot of things. Sometimes it is better to look a little deeper into something so not as many assumptions need to be made.
This equals less mistakes in forecasting situations regarding Biocurex.
Interesting that you bring up QuantRx. They have a relationship with Biocurex already.
Gold since you like the analysts so much, I will answer your question this way. VetRed will sell as many tests as are accounted for on the sales side of the ledger following the actual sales.
That statement is 100% correct. I am either a genius or I should have been a stock analyst eh...
Gold, It appears that you have been involved in too many snake oil deals in the past.
Your comments on RPC represent a form of contradictory terms or an Oxymoron.
You believe one Must have minimum quantity to make sales work....
Gold stated,"That is the only way you can be assured that a distributor would even attempt to sell the product.
And yet you state:
"RPC has replaced several distributors signed last year because they have not made any sales.
Guess that is not the only way.
Gold, It appears that Dr. Moro is confident enough in Recaf that he does not need to twist the arms of a distributor to force them to take on minimum quantities.
In reality, the product must be in demand to fulfill the end game.
Dr. Moro has never been interested in the short term gain like some others I know.
Gold, What does this mean?
VetRed, a private company under Dutch law, will represent BioCurex's wholly owned subsidiary OncoPet Diagnostics to distribute the OncoPet RECAF™ cancer test for dogs in Europe.
Through a network of its own companies, agents and distributors, VetRed will ensure that OncoPet's RECAF™ test will reach the European Union member states.
Gold stated,"The Analyst will wait for sales results." LOL!!! That makes him a reporter then Gold. An accountant if you will.
Instead of forecasting what will happen, he reports on what DID happen.
A true analyst needs to be able to look at what will happen...Not what did happen.
A three year old can do that Gold...
Gold, Here is your new Taglich Brothers report.
On October 13, 2010, BioCurex announced a non-exclusive distribution agreement with VetRed B.V. (Netherlands) a private company that will distribute OncoPet RECAF™ cancer test for dogs in Europe.Through a network of its own companies, agents and distributors, VetRed aims to ensure the distribution throughout the European Union. Samples will be collected and sent to BioCurex's laboratories in Richmond, British Columbia, Canada for processing.
--------------------------------------------------------------------------------
On September 30, 2010, BioCurex announced the commercial launch of its RECAF blood test for cancer in dogs through its OncoPet Diagnostics subsidiary. The processing capacity of OncoPet's current testing facilities is estimated at 1,000 RECAF tests per day.
OncoPet Diagnostics will pre-sell vouchers to distributors, each valid for one test. The distributor will sell the vouchers to veterinarians who will send the voucher with the blood sample to the OncoPet testing facility. OncoPet Diagnostics has developed a software system to manage the ordering, testing and reporting process.
Company DescriptionBioCurex, Inc. (OTC BB), based in Richmond, British Columbia, Canada, is a development stage company. BioCurex has developed a broad-spectrum cancer blood test that could potentially detect several major cancers with greater accuracy than existing tests for widely used tumor markers. The company’s blood test is based on a new proprietary cancer marker named RECAF, which is found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells.
RECAF technology is covered by patents granted in the US, Europe and China and pending in other major markets.
The RECAF blood test can be formatted for use on automated instrumentation typically found in reference laboratories on in hospital laboratories. It can also be formatted for manual (individual or small-batch) tests or as a point-of-care (POC) single use rapid test for use in physicians' offices, urgent care facilities and at the bedside.
BioCurex is pursuing a dual track commercialization strategy. For development of RECAF tests on blood samples processed in automatic equipment in reference and large hospital laboratories, the company has granted Abbott Laboratories and Alere (formerly Inverness Innovative Medical) semi-exclusive licenses. The company is allowed to grant a third semi-exclusive license for automated testing.
Through its own efforts, the company aims to develop and commercialize RECAF manual tests not processed on automatic equipment, POC rapid tests for the physicians' office, including all other single-format potential uses and all tests for veterinary applications. Taglich Research
Gold, there are not many people or companies interested in a blood clotting diagnostic test such as your Radiant Pharma when it comes to cancer issues...
Maybe they would be better suited in selling tests to monitor blood clots or for potential infections for patients who recently had surgery than they would for attempting to find blood clots in individuals who may have cancer...
As previously posted, You continue to compare RPC with Recaf as a cancer diagnostic test. I would choose Recaf over RPC any day...
It is no wonder the doctors are hesitant in using RPC for cancer tests. Maybe you should be comparing RPC with the Digital Rectal Exam. They are closer in comparison.
Gold stated," Radient Pharmaceuticals has been doing a similar process of signing distributors for their Onko Sure test for over a year now for specific countries or regions. Unfortunately, the contracts do not have requirements for minimum yearly sales and thus far, RPC has gotten few sales at all from their distributors."
Score one for Dr. Moro and the team!
I wonder if VetRed will do any advertising Gold?
http://www.vetred.net/index.php?option=com_content&view=article&id=3&Itemid=24
VetRed is in the process of adding Oncopet to their site.
http://www.vetred.net/index.php?option=com_content&view=article&id=3&Itemid=24
Maybe this will temper your concern Gold.
NEWS...
http://www.dailyfinance.com/rtn/pr/biocurex-announces-distribution-agreement-for-the-european-union-for-its-oncopet-recaf-tm-cancer-test-for-animals/rfid376381273/?channel=pf
Gold, You seem concerned?
Maybe you could advertise for Biocurex?
You could start with the DRE and then ease into a simple blood test.
You know...Tell all the Vets about the benefits of DRE's over Doggy Recaf....
There is no waiting time for the DRE result.
The DRE is exact science and has no false positives or false negatives. No follow up tests required??? Correct Gold?
Depending on the doctors arm length (reach) ( He / she ) can check the other vital organs such as the entire colon, ovaries, cervix, liver, lung, breast etc. In the process of reaching that deep, some blood may be present in which case the doc could review it under the microscope for signs of leukaemia?
Did you ask Dr. Moro if he was implementing a marketing program or did you just assume that he is not?
Remember Gold, according to the Taglich Report, Biocurex has super fantastic possibilities to rake in a TON of Money.
Who said things look bleak Gold?
Are you refering to your reaction or that of the share holders Gold? On what do you base your theory? Speculation?
Gold, In time you will see the light,If you choose to do so...
Eventually though you will have no choice but to figure it out. But by then you will have missed the boat.
I spoke with a local Vet today concerning Recaf. I asked if the test would be useful. The answer was YES. He particularly liked the fact that it was a UNIVERSAL test i.e not a test for only one type of cancer.
He explained that unless a dog is at the end of its anticipated life span, more people than not elect to treat their animal if cancer is diagnosed.
Following are symptoms of canine cancer. Any one of these could also be a non cancerous symptom. Recaf definitely has its place in assisting Vets in their quest to diagnose a dogs ailements.
Abnormal swellings that continue to grow, especially in the lymph nodes.
Sores do not heal.
Bleeding or discharge from the mouth, nose, urinary tract, rectum, or vagina.
Offensive odor.
Difficulty eating or swallowing.
Difficulty breathing.
Difficulting urinating or defecating.
Hesitation to exercise or loss of energy.
Loss of appetite, weight loss.
Persistent lameness or stiffness of movement.
Lumps in the breast area.
Abnormality or difference in size of testicles.
Diagnosis
Veterinarians use a needle and syringe to extract a few cells from a lump or bump for examination under a microscope. If abnormal cells appear, a biopsy – surgical removal of a piece of tissue for microscopic examination – can be done. Cells from the biopsy tissue are then examined under the microscope and the tumor is assessed as high grade (aggressive), intermediate, or low-grade (slow-growing).
Following discovery of the malignancy and grading its growth rate, veterinarians determine the stage of infection, the potential outcome of the particular type of malignancy, and devise a treatment protocol.
Imaging technology using x-rays, ultrasound, magnetic resonance imaging, and nuclear scintigraphy (scans) are helpful as diagnostic tools and in monitoring the progress of treatment plans.
Ultrasonography enables the veterinarian to see and assess neoplasms that may or may not be externally palpable and to safely direct biopsy instruments for gathering tissue samples for biopsy. A CT (x-ray computed tomography) scan or an MRI may find a brain tumor that does not show up on skull radiographs. X-rays are commonly available in veterinary clinics; ultrasound equipment is becoming more common, but MRI and CT technology is generally not in widespread use.
--------------------------------------------------------------------------------
Treatment
The most common treatments for cancer are surgical excision, radiation, and tumor-killing drugs. Choice of method depends on the type of tumor, whether it has or is likely to metastasize, and how far it has progressed.
Once the presence of disease has been affirmed, owners and their veterinarians have some decisions to make about treatment potential and quality of life for the dog as well as determining the best treatment choice for the type of malignancy involved. It’s a time of tough decisions as owners consider the dog’s age and general health as well as the cost and potential outcome of prolonged aggressive treatment.
Surgical excision is preferred when the tumor is small, is easily accessible, or is located in a spot that makes it painful. The object of surgery is to remove the entire tumor and leave clean edges that have no cancer cells.
Radiation is useful on cancers of the limbs, for locally invasive tumors such as nasal carcinomas, and for tumors that cannot be completely removed surgically. Success is best when the tumor is small; large cancers are surgically removed before the treatments and radiation is used to stop further growth of any cells missed in the surgery.
Radiation works best on those cancers that are low-grade — the ones that are localized and metastasize late in the course of the disease. It is effective on malignancies on the limbs, chest, face, and mouth, but is not indicated for brain, spinal cord, or intestinal cancers. Once the cancer has spread to internal organs, chemotherapy or a combination of radiation and chemotherapy may be appropriate.
Radiation sterilizes the cancer cells so they cannot divide. Scar tissue may cause the lump to remain, however. The treatment is not painful, but does have some side effects, including hair loss at the tumor site, skin burn similar to sunburn, and occasionally ulcerated areas. The side effects begin towards the end of the treatment period and generally subside in about two weeks.
Chemotherapy, which attacks rapidly-dividing cells, can be used as the primary treatment for cancers such as lymphosarcma or leukemia and in conjunction with surgery or radiation for other types of the disease.
Veterinarians use the same drugs used by human oncologists, but dogs do not generally suffer the side effects of hair loss and nausea that are experienced by human cancer patients. Because chemotherapy in dogs is generally used to prolong life, not cure the cancer, lower doses and fewer drug combinations are used.
Gold, I have been a little busy lately. I don't have the same free time as those "RETIRED" 60 to 90 year olds +/- do to post about stocks that they claim to have no financial interest in.
Before we get into your questions, I wanted to put your post into perspective.
I have never had even one DRE let alone two per year like you. by the way, do you remember what the specificity and sensitivity is for all of those DRE's you have been paying so much money for? Wonder if the DRE is better or worse than that of a Doggy Recaf test. I mean you made a decision to pay more than $120 dollars per test and relied upon the information right? Gosh Gold...You could have had any number of other cancers raging out of control at the same time the rubber gloved guy was writing up your clean report for a worthless test that you relied upon. And now you want to discuss a fantastic test. Seems fair to ask the same questions of you for your DRE test so that we can compare and contrast them upon your response. I look forward to your immediate response.
1) A dog is negative at the 99% specificity level, negative for the 95% specificity but positive for the 90% specificity level, what do you do?
The cutoff for +/- is lower at 90% specificity than at 95% and much lower than at 99% specificity. That means the dog does not have much RECAF in blood because otherwise it would be above the cutoff for 95% specificity. In the example, there is no suspicion that the dog has cancer and therefore we are talking about screening.
Given the small percentage of cancer among asymptomatic dogs (which depends on the age, breed, etc), the choice of an exceedingly low specificity resulting in an unnecessary number of false positives and the low amount of RECAF discussed above, this is what common sense suggests:
a) Examine the animal thoroughly because maybe there IS a cancer that went unnoticed to the owner but is picked by the vet.
b) This is an owner who cares about the welfare of his/her dog and is willing to spend the money. He/she likely takes the dog to the vet regularly for checkups.
It would be amazing that the vet took blood to carry out a RECAF test and did not do any other blood test. Thus, consider all other blood parameters (e.g. does the dog have anemia?) together with the examination and the RECAF value. It is clearly spelled in the Oncopet site: "6) The OncoPet RECAF™ test is NOT, by itself, conclusive of the presence or absence of cancer and its results can only be assessed as an aid in the detection or monitoring of cancer in relation to the history, medical signs, symptoms and the overall condition of the animal."
c) If (a) or (b) provides any indication that there might be cancer the animal should be studied more thoroughly.
d) If either (a) or (b) are negative chances are that the dog does not have cancer. To play it safe, the animal could be tested again in 1-2 months (remember, this is a caring dog owner and therefore if he/she takes the dog to the vet for another checkups he/she will not have a problem taking it to the vet in 1-2 months).
e) If after 2 months RECAF goes down, great. If it is the same, the vet now has a baseline value to compare with next time. If RECAF is significantly higher then the chances of cancer are much higher and the vet should act accordingly (and yes, they do know how to act when there is a high suspicion of cancer).
The same applies to the other examples: The higher the amount of RECAF and the higher the specificity, the more likely it is that the animal has cancer. In all cases, the vet has to evaluate the dog's diagnosis using ALL clinical, blood tests (RECAF being just one of them) and imaging if so required.
Dr. Moro...A few words of encouragement!
A cancer doctor with 30 years experience said today," Whoever figures out how to diagnose cancer earlier at its beginning stages will be the Nobel prize winner.
He said the mammogram is not worth taking because it finds the cancer too late.
He also said while the ultrasound does pick up on cancer, it also happens in the later stages."
The ultimate test would find cancer in its earliest stages when there is time to react.
Gold, That was you if I remember correctly. In your eyes any BOCX volume over 115,000 shares was a huge volume day.
Gold stated,"As for his US patent, it expires in September 2014."
That would show that the US. patent is in good order then wouldn't it.
You seem to think you are in your 60's or 90's depending on which board you are posting on. In this case, You may expire before the patent does in a company that you hold no shares in.
While your expiration is not renewable, patents are Gold.
But then again, You have no shares in a company that you post about multiple times each day for the last number of years.
That is a bit odd isn't it?
Gold, My understanding is that the patents are in good order.
Remember you have been wrong in the past concerning Biocurex's patents Gold.
How many times must I wait for a cure for cancer Gold?
Should we all sell our Big Pharma holdings because they have not performed at the pace we would like?
Gold stated,"If you really knew anything at all of that significance, you would be considered and insider and would be stupid for posting on this board."
Does this mean that you should discontinue posting on this board?
President Nixon called the charge in the war against cancer 40 years ago Gold.
A long, long time ago. How is that progressing? Please write to each of the companies in the below link and tell them we are pissed off that after 40 years they have not commercialized a cure for cancer.
http://en.wikipedia.org/wiki/List_of_pharmaceutical_companies
Gold, You keep asking those same questions over and over. You really havn't figured out what is going on behind the scenes have you...
I thought you were sharper than that. I am counting on you to figure it out before the big announcement.
Ever build a puzzle before?
Dr. Moro may have said it could be used as a predicate, but you continue to place DR-70 and Recaf in an arena and argue that if DR-70 has poor sales then so will Recaf.
These are Two completely different uses of the DR-70 reference Gold.
Gold, Why do you continue to compare DR-70 to Recaf?
Dr-70 has an awful amount of issues in attempting to try to diagnose a cancer because to many other issues cloud its use.
It even has issues diagnose lung cancers. It also shows false positives as it is elevated in all of the the following conditions:
Infection, Neurogenic bladder + chronic infection, Pneumonia & Fasciitis (Necrotizing) Klebsiella, acute pneumonia, body burns, chest trauma-surgery, Renal insufficiency-jaundice, Rheumatoid Arthristis, cellutitus of knee and sepsis.
So you continue to use a subpar test to compare it to Recaf.
It is no wonder doctors don't want to use DR-70 for cancer diagnosis or Monitoring.
Gold stated,"RPC cannot get any significant sales of their approved test."
Rpc's test is a test to indicate blood clotting Gold. why would anyone want to use a blood clot test to diagnose cancer?
This is what Alere has to say.
Our research and development efforts continue to focus on developing diagnostic technology platforms, including our Stirling CHF and Clondiag molecular devices, which will facilitate movement of testing from the hospital and central laboratory to the physician's office and, ultimately, the home. Additionally, through our strong pipeline of novel proteins or combinations of proteins that function as disease biomarkers, we are developing new point-of-care tests targeted toward all of our areas of focus.
Gold,
I can make the statement that NONE of the Cancer related companies in the world APPEAR to be actively pursuing commercialization of CANCER CURES.
Does this mean that companies are not actively pursuing a cure for cancer?
They have spent trillions and have been wanting for atleast the last 40 years to cure cancer but have not yet cured it so therefore they are not actively pursuing a cure correct?
Further the world must have abandoned the quest to cure cancer since it has been over 40 years since they began the quest with no commercialized cure in sight...
Gold stated,"Taglich analyst concluded that neither licensee was actively pursuing commercilization of RECAF."
WRONG! Gold.
Let us again go through the exercise...
[color=red]Please type the exact words from the report. It says nothing of conclusions regarding the licensees.
[/color]
Gold, You said the correct statement yourself,"Some posters here have objected to the Taglich Report given the company a "neutral rating"
There is only one entity Slamming the stock Gold...Care to guess who?
How many Digital rectal exams did you have before you stopped?
Remember to multiply the years X 2 because I remember you saying that you thew money away twice per year before you figured out the test was terrible.
Question? While the I-phone has been distributed only through
AT & T,could Apple have marketed the phone by itself and sold more phones?
Did they take any time to decide which avenue they were going to take on this issue or did they just flip a coin?
Gold, I heard that one a different way.
It was a young man just like you mentioned and each time he bent over to see what was in the bucket, they shoved a rubber glove deep into the ships stern and called it a Digital Rectal Exam. They always told him afterwards that he was as healthy as a seabat.
The young man jumped up, looked around and then eventually bent over again again and the result was exactly the same every time.
I yelled down and asked him "what did it look like?" He replied, "I don't know, someone keeps sticking me in the stern with a rubber glove. The real funny part is they charged him an admission for each peak. Must have been very expensive rubber gloves in the time.
While the young man grew older (Some say he is in his 60's and some say in his 90's) Dr. Moro may be able to help this man see what is really in the bucket. Are you tired of being stuck in the stern of the ship when you attempt to look under that burlap?
They are readying a simple blood test that takes the place of the glove in the stern. It turns out that the glove in the stern was not as accurate as some of those academically very bright individuals that had a 4.0 grade average thought.
Looks like the stock closed in the green today.
I am confident that made your day.